相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Racial and ethnic disparities in outcomes with radiation therapy for rectal adenocarcinoma
Wendy Lee et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2012)
Functional Performance and Quality of Life in Patients With Squamous Esophageal Carcinoma Receiving Surgery or Chemoradiation Results From a Randomized Trial
Anthony Yuen Bun Teoh et al.
ANNALS OF SURGERY (2011)
Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer
M. Kranzfelder et al.
BRITISH JOURNAL OF SURGERY (2011)
Tumor length assessed by miniprobe endosonography can predict the survival of the advanced esophageal squamous cell carcinoma with stricture receiving concurrent chemoradiation
W-L Chang et al.
DISEASES OF THE ESOPHAGUS (2011)
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
Katrin M. Sjoquist et al.
LANCET ONCOLOGY (2011)
NRF2 Mutation Confers Malignant Potential and Resistance to Chemoradiation Therapy in Advanced Esophageal Squamous Cancer
Tatsuhiro Shibata et al.
NEOPLASIA (2011)
Pathologic Response after Neoadjuvant Therapy is the Major Determinant of Survival in Patients with Esophageal Cancer
Kenneth L. Meredith et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction
Thomas W. Rice et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase II study by the Swiss Group for Clinical Cancer Research (SAKK 75/02)
Christian Jost et al.
GASTROINTESTINAL ENDOSCOPY (2010)
[F-18]- Fluorodeoxyglucose-Positron Emission Tomography for the Assessment of Histopathologic Response and Prognosis After Completion of Neoadjuvant Chemoradiation in Esophageal Cancer
Daniel Vallboehmer et al.
ANNALS OF SURGERY (2009)
Meta-analysis of genetic polymorphisms and gastric cancer risk: Variability in associations according to race
Marie Loh et al.
EUROPEAN JOURNAL OF CANCER (2009)
Minimally Invasive Esophagectomy Lessons Learned From 104 Operations
Ninh T. Nguyen et al.
ANNALS OF SURGERY (2008)
Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer
Paul M. Schneider et al.
ANNALS OF SURGERY (2008)
Randomized strategical trial of chemotherapy in metastatic colorectal cancer (FFCD 2000-05): Preliminary results
O. Bouche et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus:: FFCD 9102
Laurent Bedenne et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
Val Gebski et al.
LANCET ONCOLOGY (2007)
Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer
EA Levine et al.
ANNALS OF SURGERY (2006)
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
N Thatcher et al.
LANCET (2005)
Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: Early results from the Chinese University Research Group for Esophageal Cancer (CURE)
PWY Chiu et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus
M Stahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections:: Impact on staging, disease-free survival, and outcome -: A plea for adaptation of TNM classification in upper-half esophageal carcinoma
T Lerut et al.
ANNALS OF SURGERY (2004)
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer
SG Swisher et al.
ANNALS OF THORACIC SURGERY (2004)
Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: Pathologic complete response induced by chemotherapy leads to long-term survival
SJ Darnton et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: Final results of a minnie pearl cancer research network phase II trial
AA Meluch et al.
CANCER JOURNAL (2003)
INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy
BD Minsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Curative resection for esophageal adenocarcinoma - Analysis of 100 en bloc esophagectomies
JA Hagen et al.
ANNALS OF SURGERY (2001)
Histologic tumor type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1,000 consecutive resections at a single center in the Western world
JR Siewert et al.
ANNALS OF SURGERY (2001)
Two-field dissection is enough for esophageal cancer
S Law et al.
DISEASES OF THE ESOPHAGUS (2001)
分享论文
